Ali Tabrizchi
Interventional Cardiology · Bel Air, MDNPI 1710047709
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,055 of the $65,826 with a category attached, or 89.7%. Johnson & Johnson accounts for 67.4% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $54,804 and has fallen 99.7% since, to $152 in 2023.
Across 372 payments — averaging $176.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$44K
- Amarin Pharma, Inc.$9K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$5K
- Chiesi USA, Inc.$3K
- Novartis$659
- Pfizer$630
- plus $3K from 24 others
What the payments were for
- Consulting fees$3000%
- Speaking & faculty fees$59,05590%
- Travel & lodging$2620%
- Food & beverage$6,1109%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 66 | $44,345 |
| Amarin Pharma, Inc. | 22 | $9,046 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 49 | $5,173 |
| Chiesi USA, Inc. | 5 | $3,140 |
| Novartis | 37 | $659 |
| Pfizer | 34 | $630 |
| Amgen | 27 | $502 |
| Abbott | 11 | $248 |
| Gilead | 19 | $247 |
| Boehringer Ingelheim | 12 | $217 |
| Astellas Pharma US Inc | 7 | $212 |
| AstraZeneca | 14 | $212 |
| Boston Scientific | 9 | $199 |
| Arbor Pharmaceuticals, Inc. | 10 | $148 |
| Sanofi-aventis U.S. LLC | 6 | $125 |
| Merck | 7 | $114 |
| Medtronic | 6 | $81 |
| Irhythm Technologies, Inc. | 6 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| Cardiovascular Systems Inc. | 4 | $56 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Bayer | 2 | $48 |
| Medicomp Inc | 2 | $46 |
| Preventice Services, LLC | 1 | $38 |
| Philips North America LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Lundbeck LLC | 2 | $28 |
| Biotronik Inc. | 2 | $27 |
| Infobionic, Inc | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,826 in reported general payments places this provider in the 85th percentile of 71 interventional cardiology providers in Maryland.
Other interventional cardiology in Bel Air
- Amir NajafiBel Air$82K
- Vinay SatwahGreenbelt$679K
- Aloke FinnBaltimore$575K
- Michael ChenRockville$241K
- John WangBaltimore$138K
- Steven HearneSalisbury$100K
- Diljon ChahalBaltimore$78K
- Joseph CinderellaSalisbury$72K
- Homam IbrahimSilver Spring$49K
- Jon ResarBaltimore$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.